Allergy and Asthma Proceedings

Article	Citations
Impact of steroids on the immune profiles of children with asthma living in the inner-city	85
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	29
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	28
Venom allergen immunotherapy	27
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	24
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	21
Future directions in allergen immunotherapy	21
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	19
Operationalizing shared decision making in clinical practice	19
Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts	19
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	19
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	19
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	17
For the Patient	17
For the Patient	17
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	16
Evaluation and management of chronic cough in adults	15
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy	15
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps	14
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	14
Optimizing diagnostic approaches for allergic bronchopulmonary aspergillosis: Comparative analysis of IgG/IgE ELISA and serum precipitins assays	14
Recurrent full-body rash following chemotherapy initiation in a multiple myeloma patient	14
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma	14
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	13
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	13

Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	12
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	12
For the Patient	12
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	12
Effects of mechanical washing and drying on the removal of pet allergens	12
Utility of basophil activation tests in the diagnosis of cross-intolerance to nonsteroidal anti-inflammatory drug reactions	12
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	12
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii	11
A tribute to allergy and immunology fellowship training program directors and to the fellows they train	11
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy	11
Navigating the management complexity in long-term asymptomatic immunodeficiency	11
For the patient	11
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?	11
Diagnostic utility of basophil CD203c expression in β-lactam allergy	11
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities	11
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment	11
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	10
Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze	10
Benralizumab in the management of rare primary eosinophilic lung diseases	10
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	10
Metal implant allergy: A retrospective cohort analysis at a university allergy practice	10
The long COVID syndrome: A conundrum for the allergist/immunologist	10
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab	10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention	10
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii	10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination	10
Cost-effectiveness of school integrated pest management and air filtration in students with asthma	9
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	9
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	9
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema	9
Primary Immunodeficiency: Specific antibody deficiency with normal IgG	9
Evaluation of atopic diseases in patients with allergic contact dermatitis	9
The association of timothy grass allergy and cat ownership on cat sensitization	8
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization	8
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	8
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis	8
Hematopoietic stem cell transplantation for primary immunodeficiency	8
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	8
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	8
Curcumin does not significantly affect immediate skin tests	8
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	8
Rethinking the management of hereditary angioedema	8
Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review	8
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	8
For the Patient	8
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	8
Overview of secondary immunodeficiency	8
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience	7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	7

Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations	7
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough	7
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers	7
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	7
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	7
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study	7
Immunodeficiency: Burden of Illness	7
Assessing cross-reactivity in allergen immunotherapy	7
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	7
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	7
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic	7
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis	7
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)	6
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	6
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis	6
Cat allergy in children and the effect of the COVID-19 pandemic	6
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy	6
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease	6
For the patient	6
Winged hymenoptera: Discordance between In vitro and In vivo sensitization	6
Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis	6
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis	6
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors	6
Genetically-determined defects of T cell development	6
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria	6
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida	6
A masquerade of recurrent anaphylaxis	6
Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal	6
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience	6
Expanding horizons of omalizumab: New frontiers in asthma and beyond	6
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema	6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	6
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma	6
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	6
Treatment options for moderate to severe atopic dermatitis	5
Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies	5
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease	5
Clinical implications of asthma endotypes and phenotypes	5
Integrating innovation and shared decision-making in allergy and immunology practice	5
The lymphocyte-eosinophil to neutrophil-monocyte ratio as a potential composite biomarker associated with asthma exacerbations in adults	5
Comorbidity burden in patients with anaphylaxis: A 25-year nationwide population-based matched case‐control study	5
Comprehensive assessment of allergic manifestations including drug hypersensitivity in adult patients with inborn errors of immunity	5
The COVID-19 impact on severe uncontrolled asthma costs and biologic use	5
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines	5
Successful rapid liposomal amphotericin B desensitization in pediatric case series	5
Unmasking multifactorial dermatitis: The case for comprehensive diagnostic guidelines in adult atopic dermatitis	5
Peptide immunotherapy for aeroallergens	5
Anaphylaxis: Long-term management and resources	5
Comparison of clinical characteristics in primary immunodeficiency patients based on the presence of autoimmunity or autoinflammation	5
A review of allergen immunotherapy in asthma	5
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study	5
Treatment of eosinophilic esophagitis with immune modulating agents	5
Across the arc of allergy: From maternal immune tolerance to food sensitization pathways and lifesaving anaphylaxis care	5
Assessment of mask use on oxygen saturation in adults and children with asthma	4
Is atopic comorbidity increased in proctocolitis?	4
Management and referral patterns for new-onset chronic cough in primary care patients	4
Atopic dermatitis: Best of guidelines and yardstick	4
Aeroallergen immunotherapy update: Developments since the third Practice Parameter	4
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level	4
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children	4
Reply	4
Selective immunoglobulin E deficiency and its association with autoimmune and autoinflammatory diseases	4
Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications	4
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis	4
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma	4
In-vivo allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites	4
Clinical predictors of breakthrough reactions during initial rapid drug desensitizations to platinum chemotherapeutics	4
For the patient	4
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches	4
Comparative analysis of demographic and clinical features in common variable immunodeficiency and selective immunoglobulin G deficiency	4
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance	4
Allergy immunotherapy for allergic fungal respiratory diseases	4
Evaluation of direct oral provocation test results in mild cutaneous reactions to cephalosporins in children	4
An infant with chronic relapsing urticaria	4
Specific immunoglobulin E for aeroallergens: 0.35 kUA/L cutoff value is too low	4
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy	4
The utility of shared decision making in the management of hereditary angioedema	4
Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies	3
Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes	3
The medical management of chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory in the biologic age	3

Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub	3
Caregiver perceptions of β-lactam allergy testing for serum sickness-like reactions	3
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease	3
Health disparities investigated in a primary care penicillin allergy removal pathway	3
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab	3
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing	3
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist	3
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease	3
Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts	3
The challenge of neurologic disease for the allergist/immunologist	3
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation	3
Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings	3
Relationship between autoimmune diseases and serum basal immunoglobulin E levels in patients with common variable immunodeficiency	3
Accelerated/rush allergen immunotherapy	3
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes	3
Oral immunotherapy with sunflower seed butter and a review of seed allergy	3
Impact of baseline body mass index on asthma incidence in middle-aged and elderly populations: A prospective analysis from China	3
For the patient	3
The complexities of allergic diseases continue to challenge the allergist-immunologist	3
Single-bag rapid drug desensitization for chemotherapeutic hypersensitivity reactions: A single-center experience	3
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD	3
Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up	3
Managing food allergies in each stage of life	3
Impact of nasal congestion on intranasal rescue medication absorption and efficacy: A systematic review	3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy	3
Allergic comorbidities in fibromyalgia	3
Capturing total steroid burden in patients with atopic dermatitis and asthma	3
Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test	3
Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005‐2018	3
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis	2
Clinical characteristics and biological treatment responses of patients with late-onset asthma phenotype	2
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS	2
Immunoglobulin therapy for immunodeficiency	2
For the patient	2
What to do when your adult patient with severe asthma does not respond to a biologic	2
Cow’s milk protein allergy: A risk factor for infections in infants?	2
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist	2
Eosinophilic esophagitis: from discovery to effective treatment	2
For the Patient	2
The relationship of D. pteronyssinus allergic component sIgE and sIgG4 in house dust mite allergic rhinitis or/and allergic asthma patients	2
Food allergy referral patterns from 2013‐2015 to 2016‐2018 at Texas Children’s Hospital	2
Health disparities in hymenoptera venom allergy management	2
Angioedema without urticaria: Diagnosis and management	2
Food allergy concurrent with atopic dermatitis: Correlation with age of onset and severity	2
Biologic treatment discontinuation in severe asthma: A real-life study on factors influencing clinical remission and physician decision-making	2
Military accession, retention, and deployment: Defining the role of the allergy consultant	2
For the patient	2
New insights in the optimal diagnosis and management of food allergy	2
Association of EDN levels in patients with asthma and correlation with FEV1%: A meta-analysis	2
The evaluation of melatonin levels in chronic spontaneous urticaria: A case control study	2
Scroll, like, diagnose? Evaluating mast cell activation syndrome information on TikTok	2
Current and emerging therapies for eosinophilic esophagitis	2
Abstracts presented at the Eastern Allergy Conference May 30‐June 2, 2024, Palm Beach, Florida	2
Immunodeficiency: Complement disorders	2
Idiopathic non-mast cell angioedema: Treatment insights from global experts	2
Real world use of peanut component testing among children in the Chicago metropolitan area	2
Evaluation of diagnostic tests for suspected hypersensitivity reactions to proton pump inhibitors in children	2
To test or not to test: Lessons learned from screening infants for peanut allergy	2
Pediatric sublingual allergen immunotherapy	2
Pearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES)	2
The value of skin testing with tumor necrosis factor-inhibitors in patients with local and systemic hypersensitivity reactions	2
Incorrect perceptions of first-line treatment of severe allergic reactions with over-the-counter products and how the epinephrine drug delivery system impacts behavior	2
Hypogammaglobulinemia during infancy and atopic dermatitis	2
Variation in diagnosis and management of allergic reactions among emergency medicine and allergy immunology providers	2
Do commercial dog extracts cross-react with Felis domesticus allergen 1	2
Isotype deficiencies (IgG subclass and selective IgA, IgM, IgE deficiencies)	2
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist	2
Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure	2
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study	2
Global, regional, and national burden of asthma and risk factors from 1990 to 2021: Global Burden of Disease study 2021	2
Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia	2
Risk factors predisposing children to transient hypogammaglobulinemia of infancy	2
Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population	2
From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts	2
The relationship between childhood atopic dermatitis and asthma in an under resourced community	2
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis	2